Interpace Diagnostics Group(IDXG)
$6.00-0.20 (-3.23%)
IDXG
Interpace Diagnostics Group financials statements
$6.00
At close:-0.20 (-3.23%)
Want to see IDXG full AI Analyst Report?
Interpace Diagnostics Group (IDXG) Income Statement
413 Followers
Interpace Diagnostics Group Income Statement
Last quarter (Q2 2026), Interpace Diagnostics Group's total revenue was $9.13M, a decrease of 1.09% from the same quarter last year. In Q2, Interpace Diagnostics Group's net income was $158.00K. See Interpace Diagnostics Group’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Mar 22 |
|---|---|---|---|---|---|
| $ 38.73M | $ 46.93M | $ 40.21M | $ 31.84M | $ 41.31M | |
| $ 24.13M | $ 29.93M | $ 23.90M | $ 18.23M | $ 17.95M | |
| $ 20.05M | $ 21.82M | $ 21.10M | $ 22.07M | $ 29.68M | |
| Depreciation and Amortization | $ 821.00K | $ 748.00K | $ 1.60M | $ 2.56M | $ 5.37M |
| $ 4.76M | $ 8.36M | $ 4.41M | $ -2.27M | $ -1.33M | |
| $ 4.08M | $ 8.11M | $ 2.80M | $ -3.84M | $ -11.74M | |
| $ -310.00K | $ -1.16M | $ -1.68M | $ -2.22M | $ -1.41M | |
| $ 3.77M | $ 6.95M | $ 1.13M | $ -5.84M | $ -15.41M | |
| $ 24.57M | $ 6.70M | $ 802.00K | $ -5.87M | $ -14.75M | |
| Per Share Metrics | |||||
| Basic EPS | $ 27.75 | $ 7.10 | $ 0.95 | $ -6.90 | $ -17.85 |
| Diluted EPS | $ 4.45 | $ 2.00 | $ 0.90 | $ -6.90 | $ -17.85 |
| Weighted Average Shares Outstanding | 884.80K | 877.40K | 863.40K | 847.60K | 827.00K |
| Weighted Average Shares Outstanding (Diluted) | 5.54M | 877.40K | 872.80K | 847.60K | 827.00K |
Currency in USD

